|

Progesterone Clinical Trials

2 actively recruiting trials across 1 location

Also known as: medroxyprogesterone acetate (MPA)

Pipeline

Phase 4: 1Phase 2/3: 1

Top Sponsors

  • West China Second University Hospital1
  • University of North Carolina, Chapel Hill1

Indications

  • Major Depressive Disorder1
  • Atypical Endometrial Hyperplasia1
  • Depression1
  • Endometrial Cancer1
  • Cancer1

Other1 trial

Value of LNG-IUS as Fertility-preserving Treatment of EAH and EC
Phase 2/3

Chapel Hill, North Carolina1 trial

Ovarian Hormone Withdrawal, Anhedonia, and Reward Sensitivity in Women With Premenstrual Exacerbations of Depression

University of North Carolina, Chapel Hill

Phase 4

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.